BSE filing, NSE: DPABHUSHAN. Summary written from the filing by ALFA Finder's alert engine.
D P Abhushan Ltd: key numbers
- Share price
- ₹2,039.20
- Market cap
- ₹4,655 Cr
- Revenue (annual)
- ₹4,065 Cr
- Net profit (annual)
- ₹211.8 Cr
- P/E (TTM)
- 19.4×Sector 49.5×
- Promoter holding
- 74.89%+0.00% QoQ
- FII holding
- 0.45%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from D P Abhushan Ltd
All →D P Abhushan Preferential Issue
D.P. Abhushan replaced two proposed allottees in its ₹123.90 crore preferential equity issue via an EoGM notice corrigendum. Total consideration is unchanged; approvals remain pending.
- Value
- ₹123.9 Cr
D P Abhushan Other Announcement
D. P. Abhushan Limited filed a certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018, confirming that the regulation is not applicable as all shares are dematerialised.
D P Abhushan Annual General Meeting
D. P. Abhushan Limited has issued a notice for an Extra-ordinary General Meeting (EGM) to be held on October 29, 2026, to seek shareholder approval for preferential issuance.
D P Abhushan Annual General Meeting
D. P. Abhushan Limited announced an Extra-ordinary General Meeting on October 29, 2026, to approve a preferential fund raise of Rs. 558.01 Crore via shares and warrants.
- Value
- ₹558.0 Cr
D P Abhushan Fund Raise of ₹558 Cr
D.P. Abhushan Ltd's board approved a preferential issue of equity shares and warrants, aiming to raise a total of approximately ₹558.01 Crore.
- Value
- ₹558.0 Cr
D P Abhushan Board Meeting Date
D.P. Abhushan Limited scheduled a board meeting for October 05, 2026, to consider raising funds via preferential issue of equity shares and/or warrants.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.